Sentinel node-positivt melanom

Mette Haldrup; Lars B Stolle; Lisbeth Rosenkrantz Hölmich; Annette Chakera

Sentinel node-positivt melanom

Mette Haldrup, Lars B Stolle, Lisbeth Rosenkrantz Hölmich, Annette Chakera

Institut for Klinisk Medicin

Abstract

Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

Bidragets oversatte titel	Sentinel node-positive melanoma
Originalsprog	Dansk
Artikelnummer	V03180192
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	41
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 8 okt. 2018

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/sentinel-node-positivt-melanom

Citationsformater

@article{7663dc4efce1446bb86e9ae2e16d9b2e,

title = "Sentinel node-positivt melanom",

abstract = "Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.",

author = "Mette Haldrup and Stolle, {Lars B} and H{\"o}lmich, {Lisbeth Rosenkrantz} and Annette Chakera",

year = "2018",

month = oct,

day = "8",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "41",

}

TY - JOUR

T1 - Sentinel node-positivt melanom

AU - Haldrup, Mette

AU - Stolle, Lars B

AU - Hölmich, Lisbeth Rosenkrantz

AU - Chakera, Annette

PY - 2018/10/8

Y1 - 2018/10/8

N2 - Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

AB - Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

M3 - Tidsskriftartikel

C2 - 30327078

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 41

M1 - V03180192

ER -

Sentinel node-positivt melanom

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater